ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,692Medicare Part D Prescriptions Filled, Including Refills

Rank: 38 out of 1571

$351K Total Retail Price of All Prescriptions

Rank: 347 out of 1571

446 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
56% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

10% of this provider’s 446 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 11,956 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

14% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$28 was the average price of a prescription from this provider, compared to $99 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
LISINOPRIL 1,259 1,210 1 5
LOVASTATIN 1,088 1,027 2 33
LEVOTHYROXINE SODIUM 877 843 3 6
METFORMIN HCL 708 690 4 9
HYDROCHLOROTHIAZIDE 450 439 5 18
AMLODIPINE BESYLATE 427 421 6 2
OMEPRAZOLE 378 370 7 4
METOPROLOL TARTRATE 372 345 8 13
ALENDRONATE SODIUM 346 346 9 22
SIMVASTATIN 334 293 10 1
LOSARTAN POTASSIUM 253 234 11 17
GLYBURIDE 247 228 R 12 99
ATENOLOL 244 234 13 15
FENOFIBRATE 237 216 14 129
FINASTERIDE 236 226 15 30
METOPROLOL SUCCINATE 230 230 16 16
GEMFIBROZIL 202 185 17 142
NAPROXEN 189 167 18 98
PAROXETINE HCL 176 158 19 100
LANTUS 162 140 20 65
TRIAMTERENE-HCTZ 142 130 21 97
TRIAMTERENE-HYDROCHLOROTHIAZID 139 135 22 393
FUROSEMIDE 130 112 23 7
ATORVASTATIN CALCIUM 113 106 24 8
TAMSULOSIN HCL 109 85 25 11
CARVEDILOL 102 89 26 10
DIOVAN 90 90 27 19
HYDROCODONE-ACETAMINOPHEN 87 68 S3 28 3
INSULIN SYRINGE 86 63 29 124
GABAPENTIN 81 72 30 12
FLUTICASONE PROPIONATE 80 75 31 41
LISINOPRIL-HYDROCHLOROTHIAZIDE 76 75 32 123
ACTOS 71 43 33 92
BENAZEPRIL HCL 68 68 34 32
PRAVASTATIN SODIUM 66 66 35 26
TERAZOSIN HCL 65 65 36 137
IBUPROFEN 64 60 37 44
CIMETIDINE 61 55 38 468
CLOPIDOGREL 60 59 39 21
PANTOPRAZOLE SODIUM 56 56 40 23
CITALOPRAM HBR 50 50 41 66
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.